Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) active compounds. Its structure supports binding to neurological receptors, making it valuable in the creation of drugs targeting psychiatric and neurological disorders. Commonly employed in medicinal chemistry for designing dopamine or serotonin receptor modulators. Also utilized in research settings to explore new therapeutic agents for depression, anxiety, and schizophrenia. The fluorinated benzyl group enhances metabolic stability and bioavailability, which improves drug performance in vivo.